Assessing the Prognostic Significance of Lactate Levels and Arterial Base Excess in Patients After Pancreatic Surgery: A Retrospective Analysis
https://doi.org/10.35401/2541-9897-2024-9-2-26-33
Abstract
Background: Despite advances in surgical approaches and various treatment regimens, postoperative mortality after pancreatic surgery remains high (3.8%). Lactate levels and base excess show metabolic changes in the body and are useful prognostic markers of in-hospital mortality.
Objective: To evaluate the prognostic significance of lactate levels and arterial base excess in patients after pancreatic surgery. Materials and methods: We retrospectively analyzed a database of patients who underwent pancreatic surgery (n=134) between 2019 and 2023. The patients were grouped: group 1 (n=11) for the patients who died in the hospital in the postoperative period and group 2 (n=123) for the patients discharged from the hospital.
Results: In group 1, the lactate level at the time of admission was significantly higher than in group 2: 5.61 (2.51-11.13) mmol/L and 1.84 (1.33-2.98) mmol/L, respectively, P<.001. Changes of this parameter on day 1: 3.60 (2.41-4.24) mmol/L in group 1 and 2.27 (1.72-3.64) in group 2, P<.001. On day 2: 2.55 (1.43-3.54) mmol/L in group 1 and 1.40 (1.16-1.92) mmol/L in group 2, P=.001. On day 3: 1.85 (1.57-2.91) mmol/L in group 1 and 1.24 (1.14-1.54) mmol/L in group 2, P=.002. The base excess was also higher in group 1 compared with group 2: −7.50 (−10.75-(−5.40)) mmol/L and −4.00 (−5.30-(−2.35)) mmol/L, respectively, P=.001. Changes of this parameter on day 1: −5.20 (−6.90-(−1.40)) mmol/L in group 1 and −2.70 (−4.00-(−0.80)) in group 2, P=.002. On day 2: −1.90 (−7.00- (−1.40)) mmol/L in group 1 and 1.62 (−0.80-3.50) mmol/L in group 2, P=.006. On day 3: −1.25 (−8.00-2.3) mmol/L in group 1 and 2.55 (0.80-3.80) mmol/L in group 2, P=.027. The area under the receiver operating characteristic curve (AUROC) for relationship between lactate level and death was 0.833, 95% CI: 0.704-0.962, P<.001. The cutoff point value was 2.5 mmol/L, whereas sensitivity and specificity were 81.8% and 69.1%, respectively. The AUROC for relationship between base excess and death was 0.801, 95% CI: 0.657-0.945, P=.001. The cutoff point value was −6.6 mmol/L, whereas sensitivity and specificity were 72.7% and 84.6%, respectively. When comparing the AUROC values, we found no significant differences (P=.520). Conclusions: Arterial blood lactate and base excess are equally good at predicting in-hospital mortality in patients undergoing pancreatic surgery.
About the Authors
B. S. EzugbaiaRussian Federation
Beka S. Ezugbaia, Cand. Sci. (Med), Anesthesiologist-Intensivist, Intensive Care Division,
building 2, ulitsa Rublevskoe predmestye 2, Krasnogorsk municipal district, 143421, Moscow Region
V. A. Avetisian
Russian Federation
Vaagn A. Avetisian, Cand. Sci. (Med), Anesthesiologist-Intensivist, Anesthesiology Division
Krasnogorsk municipal district, Moscow Region
M. A. Dzhopua
Russian Federation
Maksim A. Dzhopua, Anesthesiologist-Intensivist, Anesthesiology and Resuscitation Division
Lapino, Moscow Region
G. S. Ezugbaya
Russian Federation
Georgiy S. Ezugbaya, 6th Year Student, Faculty of Pediatrics
Krasnodar
K. B. Almashova
Russian Federation
Karina B. Almashova, 6th Year Student, Faculty of Medicine
Yaroslavl
D. D. Shevchuk
Russian Federation
Daniil D. Shevchuk, Student
Krasnodar
S. A. Fedorov
Russian Federation
Sergey A. Fedorov, Cand. Sci. (Med.), Head of the Intensive Care Division
Krasnogorsk municipal district, Moscow Region
E. V. Zuev
Russian Federation
Evgeniy V. Zuev, Head of the Anesthesiology Division
Krasnogorsk municipal district, Moscow Region
V. A. Koriachkin
Russian Federation
Victor A. Koriachkin, Dr. Sci. (Med.), Professor at the Anesthesiology, Intensive Care, and Emergency Pediatrics Department named after V.I. Gordeev
Saint Petersburg
References
1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. Published correction appears in Cancer Res. 2014;74(14):4006. PMID: 24840647. https://doi.org/10.1158/0008-5472.CAN-14-0155
2. Hartwig W, Werner J, Jäger D, Debus J, Büchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013;14(11):e476–e485. PMID: 24079875. https://doi.org/10.1016/S1470-2045(13)70172-4
3. Huang L, Jansen L, Balavarca Y, et al. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut. 2019;68(1):130–139. PMID: 29158237. https://doi.org/10.1136/gutjnl-2017-314828
4. Hackert T, Sachsenmaier M, Hinz U, et al. Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Ann Surg. 2016;264(3):457–463. PMID: 27355262. https://doi.org/10.1097/SLA.0000000000001850
5. Kogan A, Preisman S, Bar A, et al. The impact of hyperlactatemia on postoperative outcome after adult cardiac surgery. J Anesth. 2012;26(2):174–178. PMID: 22113490. https://doi.org/10.1007/s00540-011-1287-0
6. Scheeren TW, Wiesenack C, Gerlach H, Marx G. Goal-directed intraoperative fluid therapy guided by stroke volume and its variation in high-risk surgical patients: a prospective randomized multicentre study. J Clin Monit Comput. 2013;27(3):225–233. PMID: 23558909. https://doi.org/10.1007/s10877-013-9461-6
7. Futier E, Constantin JM, Petit A, et al. Conservative vs restrictive individualized goal-directed fluid replacement strategy in major abdominal surgery: A prospective randomized trial. Arch Surg. 2010;145(12):1193–1200. PMID: 21173294. https://doi. org/10.1001/archsurg.2010.275
8. Kopp R, Dommann K, Rossaint R, et al. Tissue oxygen saturation as an early indicator of delayed lactate clearance after cardiac surgery: a prospective observational study. BMC Anesthesiol. 2015;15:158. PMID: 26518485. PMCID: PMC4628313. https://doi.org/10.1186/s12871-015-0140-7
9. Spiliotis J, Halkia E, Zouridis A, et al. Serum lactate as predictor of morbidity, mortality and long term survival in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Case Studies in Surgery. 2015;1(1):41–46. https:// doi.org/10.5430/css.v1n1p41
10. Hernandez G, Bellomo R, Bakker J. The ten pitfalls of lactate clearance in sepsis. Intensive Care Med. 2019;45(1):82–85. PMID: 29754310. PMCID: PMC6334727. https://doi.org/10.1007/ s00134-018-5213-x
11. Haas SA, Lange T, Saugel B, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016;42(2):202–210. PMID: 26556617. https://doi.org/10.1007/s00134-015-4127-0
12. Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol. 2016;12(10):610– 623. PMID: 27573728. https://doi.org/10.1038/nrneph.2016.113
13. Renew JR, Barbara DW, Hyder JA, Dearani JA, Rivera M, Pulido JN. Frequency and outcomes of severe hyperlactatemia after elective cardiac surgery. J Thorac Cardiovasc Surg. 2016;151(3):825–830. PMID: 26687885. https://doi.org/10.1016/j. jtcvs.2015.10.063
14. Andersen LW, Holmberg MJ, Doherty M, et al. Postoperative lactate levels and hospital length of stay after cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29(6):1454–1460. PMID: 26456273. https://doi.org/10.1053/j.jvca.2015.06.007
15. Gale SC, Kocik JF, Creath R, Crystal JS, Dombrovskiy VY. A comparison of initial lactate and initial base deficit as predictors of mortality after severe blunt trauma. J Surg Res. 2016;205(2):446–455. PMID: 27664895. https://doi.org/10.1016/j. jss.2016.06.103
16. Pfortmueller CA, Uehlinger D, von Haehling S, Schefold JC. Serum chloride levels in critical illness-the hidden story. Intensive Care Med Exp. 2018;6(1):10. PMID: 29654387. PMCID: PMC5899079. https://doi.org/10.1186/s40635-018-0174-5
17. Hernandez G, Boerma EC, Dubin A, et al. Severe abnormalities in microvascular perfused vessel density are associated to organ dysfunctions and mortality and can be predicted by hyperlactatemia and norepinephrine requirements in septic shock patients. J Crit Care. 2013;28(4):538.e9–538.e5.38E14. PMID: 23566729. https://doi.org/10.1016/j.jcrc.2012.11.022
18. Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Analytic review: interleukin-6 in surgery, trauma, and critical care: part I: basic science. J Intensive Care Med. 2011;26(1):3– 12. PMID: 21262749. PMCID: PMC6209321. https://doi.org/10.1177/0885066610395678
19. Creagh-Brown BC, De Silva AP, Ferrando-Vivas P, Harrison DA. Relationship between peak lactate and patient outcome following high-risk gastrointestinal surgery: influence of the nature of their surgery: elective versus emergency. Crit Care Med. 2016;44(5):918–925. PMID: 26757164. https://doi.org/10.1097/CCM.0000000000001567
20. Zante B, Reichenspurner H, Kubik M, Kluge S, Schefold JC, Pfortmueller CA. Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery. PLoS One. 2018;13(10):e0205309. PMID: 30289956. PMCID: PMC6173442. https://doi.org/10.1371/journal.pone.0205309
21. Davis JW, Dirks RC, Kaups KL, Tran P. Base deficit is superior to lactate in trauma. Am J Surg. 2018;215(4):682–685. PMID: 29409590. https://doi.org/10.1016/j.amjsurg.2018.01.025
22. Martin MJ, FitzSullivan E, Salim A, Brown CV, Demetriades D, Long W. Discordance between lactate and base deficit in the surgical intensive care unit: which one do you trust?. Am J Surg. 2006;191(5):625–630. PMID: 16647349. https://doi.org/10.1016/j.amjsurg.2006.02.014
Review
For citations:
Ezugbaia B.S., Avetisian V.A., Dzhopua M.A., Ezugbaya G.S., Almashova K.B., Shevchuk D.D., Fedorov S.A., Zuev E.V., Koriachkin V.A. Assessing the Prognostic Significance of Lactate Levels and Arterial Base Excess in Patients After Pancreatic Surgery: A Retrospective Analysis. Innovative Medicine of Kuban. 2024;(2):26-33. (In Russ.) https://doi.org/10.35401/2541-9897-2024-9-2-26-33